National Coverage Determination (NCD) for External Counterpulsation Therapy

This document from the Centers for Medicare & Medicaid Services (CMS) provides details and context for National Coverage Determination (NCD) 20-07 concerning External Counterpulsation (ECP) Therapy. It outlines the evidence considered by CMS in making coverage decisions for ECP therapy, particularly for patients with advanced heart failure, and references the existing NCD.

Healthcare providers and patients should review the details of NCD-2023-0003-0001 for clarity on current coverage parameters for ECP therapy. While this notice does not introduce new requirements or deadlines, it serves as a reference for understanding CMS's stance and the evidence base supporting coverage decisions for this treatment modality.